+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 89Years
All Genders
ID05591040

Evaluating Biofeedback vs Standard Therapy for Swallowing Problems After Stroke A Multicenter Randomized Controlled Trial in Adults

Led by IRCCS San Camillo, Venezia, Italy · Updated on 2026-03-27

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

I

IRCCS San Camillo, Venezia, Italy

Lead Sponsor

O

Ospedale Policlinico San Martino

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating whether biofeedback treatment is more effective than standard verbal feedback training in helping people recover from dysphagia after a stroke. This multicenter randomized controlled study will enroll 100 patients who have had a stroke and experience swallowing difficulties. The goal is to compare the recovery of swallowing function between those receiving biofeedback and those receiving conventional therapy without visual feedback. Participants will undergo 20 sessions over 4 weeks, attending five one-hour sessions each week. In the biofeedback group, sensors will be placed on the mylohyoid muscle to provide real-time visual feedback on muscle activity during swallowing exercises. The control group will perform the same swallowing maneuvers but will receive only verbal feedback from a speech therapist. Both groups will use effortful swallow techniques, timing and coordination tasks, and the Masako maneuver during training. Before starting treatment, and at two follow-up pointsafter 4 weeks of therapy and again two months laterpatients will have clinical and instrumental evaluations including fibroendoscopy and several swallowing function scales. Researchers will measure swallowing efficacy, penetrationaspiration, pharyngeal residues, and quality of life related to swallowing. Data will be analyzed statistically to assess treatment effects and safety throughout the study duration.

CONDITIONS

Brief Title

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia

Who Can Participate

Age: 18Years - 89Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • First stroke injury
  • Stroke onset more than six weeks prior
  • Presence of dysphagia
  • Good comprehension with Token Test score not below PT 53
  • Good eyesight and hearing, or adequately corrected
Not Eligible

You will not qualify if you...

  • Conditions preventing good electromyographic signal recording such as skin infection, wound, or dermatitis in the submandibular area
  • Severe illnesses affecting cooperation like fever, infections, metabolic problems, or serious cardiac insufficiency
  • Serious dystonia or unintentional movements
  • Disorders of consciousness
  • Encephalopathy due to multiple infarcts
  • Inability to sustain the experimental treatment
  • Other neurological diseases, e.g., Parkinson disease

Research Team

S

Sara Nordio

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here